Yasunori Kaneko insider trades
Open-market stock purchases and sales by Yasunori Kaneko, Director at Arcus Biosciences, Inc, from SEC Form 4 filings since Dec 5, 2017.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +102%.